---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-25-000032"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T06:03:31.723425+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NYSE American accepts AEON's compliance plan; delisting risk deferred to Aug 2026

## Summary
- NYSE American accepted AEON's compliance plan on April 22, 2025, granting until August 3, 2026 to meet listing standards under Sections 1003(a)(i)-(iii).
- AEON remains listed on NYSE American under symbol AEON during the Plan Period, subject to periodic progress reviews.
- Failure to regain compliance or make sufficient progress by August 3, 2026 may lead to delisting proceedings.
- Non-compliance was first disclosed in February 2025; plan submission deadline was March 5, 2025.

## SEC filing metadata
- accession: 0001837607-25-000032
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/0001837607-25-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/aeon-20250422x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-25-000032
- JSON: https://secwatch.observer/filing/0001837607-25-000032.json
- Plain text: https://secwatch.observer/filing/0001837607-25-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.